Teva | Stock Buy Or Sell

Most major brokerages have raised their expectations for TEVA in 2026, citing a strong research and development (R&D) pipeline and cost-cutting measures.

: $38.78 (approximately 26% upside from recent trading prices). High Estimate : $45.00 (The Goldman Sachs Group). Low Estimate : $26.00. teva stock buy or sell

: 10 Buy/Strong Buy ratings, 0 Hold, and 1 Sell recommendation. Key Investment Highlights Teva Pharmaceutical Industries Ltd. - News - Press Releases Most major brokerages have raised their expectations for